DalšíDalší průvodce
Pravidla FTC pro umělou inteligenci v reklamě
Společnost
PRŮVODCE společností
The 2024 HHS Section 1557 rule includes 45 CFR 92.210, requiring covered entities to make reasonable efforts to identify and mitigate discrimination risks from patient care decision support tools.
Poslechněte si tento návodAI-vyprávěný · ~3 min
HHS’s 2026 notice describes partial vacatur of gender-identity provisions; it does not describe §92.210 as vacated.
Section 1557 of the Affordable Care Act prohibits discrimination in covered health programs and activities on specified protected grounds. HHS’s 2024 final rule added 45 CFR 92.210 on nondiscrimination in the use of patient care decision support tools. The rule defines these tools broadly to include automated or non-automated methods used by a covered entity to support clinical decision-making, such as screening, risk prediction, diagnosis, treatment planning, health-care operations, and resource allocation as applied to patients. It therefore is not limited to machine-learning models. Covered entities must make reasonable efforts to identify patient care decision support tools that use input variables or factors measuring race, color, national origin, sex, age, or disability, and make reasonable efforts to mitigate the risk that their use discriminates on those bases. The rule does not categorically ban every tool that uses a protected characteristic. HHS states that a covered entity may routinely change tools and did not add a requirement to notify patients about each tool’s training data or assumptions. The legal status must be described carefully. HHS announced in June 2026 that a federal court had vacated specific provisions of the 2024 rule concerning expanded interpretations of sex discrimination tied to gender identity. HHS also said it would continue enforcement of protections involving race, color, national origin, age, disability, and unaffected aspects of sex discrimination. That notice does not say §92.210’s clinical decision-support provision was vacated. Covered entities should monitor court orders and HHS notices rather than assume the entire 2024 rule is either fully enforceable in all respects or entirely void. A covered provider, payer, or health program should inventory patient decision tools, identify which ones use factors related to protected characteristics, assess potential disparate effects, and document reasonable mitigation. Review vendor materials, validate tools for the intended population and setting, monitor performance, and retain a path to correct clinical decisions. Other civil-rights, privacy, device, and state laws may also apply.
A hospital identifies a risk-scoring tool that uses race-related variables and assesses its effect on care access.
A health plan reviews a utilization-management algorithm and its impact across disability groups.
A provider documents why a decision-support tool is appropriate for its patient population and workflow.
A compliance team distinguishes §92.210 from vacated gender-identity provisions when reading the 2026 HHS notice.
Section 1557 litigation and HHS implementation notices can change which provisions OCR enforces. The June 2026 HHS notice identifies the provisions affected by the Tennessee v. Kennedy judgment and states that other core protections remain in effect. Covered entities should consult the operative regulation, current HHS notices, and specific court orders before making compliance decisions. Track future amendments and update clinical-tool inventories when rules change. The June 2026 notice describes partial vacatur of gender-identity provisions, while stating core protections remain. Check current HHS notices and court orders before applying the rule.
Newsletter zdarma
Tři ověřené příběhy ze světa AI každý všední den ráno, psané srozumitelnou angličtinou. Navždy zdarma, bez reklam.
Jeden e-mail každý všední den. Odhlásit se můžete jedním kliknutím. Vaši adresu nikdy neprodáváme ani nesdílíme.
Otestujte se
Okamžitá zpětná vazba ke každé odpovědi a sdílitelný certifikát s ověřitelným ID po absolvování kurzu.
Podpořte bezplatnou AI vzdělávání. AI Understanding je nezisková organizace 501(c)(3) — žádné reklamy, žádná platba za přístup, nikdy. Darujte
The 2024 HHS Section 1557 rule includes 45 CFR 92.210, requiring covered entities to make reasonable efforts to identify and mitigate discrimination risks from patient care decision support tools. HHS’s 2026 notice describes partial vacatur of gender-identity provisions; it does not describe §92.210 as vacated.
The 2024 HHS final rule added §92.210 for nondiscrimination in these tools.
The definition includes automated and non-automated tools that support clinical decisions.
Section 92.210 requires identification and reasonable mitigation.
HHS described specific provisions affected and other protections remaining.
HHS defines the tools to include automated and non-automated methods.
Učte se dál
Pro toto téma bylo vybráno více průvodců
DalšíDalší průvodce
Pravidla FTC pro umělou inteligenci v reklamě
Společnost